Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial

Published:2014-03 Issue:3 Volume:13 Page:268-275
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Low Phillip A,Robertson David,Gilman Sid,Kaufmann Horacio,Singer Wolfgang,Biaggioni Italo,Freeman Roy,Perlman Susan,Hauser Robert A,Cheshire William,Lessig Stephanie,Vernino Steven,Mandrekar Jay,Dupont William D,Chelimsky Thomas,Galpern Wendy R

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference42 articles.

1. Second consensus conference on the diagnosis of multiple system atrophy;Gilman;Neurology,2008

2. Cellular pathology in multiple system atrophy;Wakabayashi;Neuropathology,2006

3. Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy;Benarroch;Neurology,2002

4. Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy;Benarroch;Brain,2006

5. Multiple system atrophy: alpha-synuclein and neuronal degeneration;Yoshida;Neuropathology,2007

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. White Matter Abnormalities Track Disease Progression in Multiple System Atrophy;Movement Disorders Clinical Practice;2024-06-24

2. Recent Advances in Clinical Trials in Multiple System Atrophy;Current Neurology and Neuroscience Reports;2024-02-28

3. High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial;eClinicalMedicine;2023-05

4. Ataxia Scales for the Clinical Evaluation;Essentials of Cerebellum and Cerebellar Disorders;2023

5. Coenzyme Q10 in Multiple System Atrophy;Contemporary Clinical Neuroscience;2023